Fungus are one of the most popular and least researched medicinal plants around.
But new research from researchers at the University of Queensland shows they can help with brain healing, helping prevent Alzheimer’s and Parkinson’s.
The research was published in Nature Medicine.
The fungus is found in all parts of the world.
Fungicide resistant plants are one example of how new species of fungus have been created to take advantage of the herbicide resistance to control pests.
It’s a very important step towards eradicating pests from our garden.
Professor Pauline O’Connor from the University’s Department of Plant Biology, said it was a very exciting development for medicinal mushrooms.
“It was exciting to see the results of this research because it really helps us understand how fungi act on our bodies, and how they work together to combat diseases,” she said.
The researchers discovered the new study had a positive impact on Alzheimer’s disease.
“We showed that a fungus can act as a therapeutic agent in mice, which is very interesting because this is the first time we’ve found such a compound to prevent the progression of Alzheimer’s,” Professor O’Connors said.
“If this compound is able to help treat Alzheimer’s, it could have huge implications for future therapies, as well as helping us to improve the efficacy of the drug in people.”
She said it would also be interesting to look at how other species of fungi interact with drugs and how this could lead to new medicinal compounds.
“Fungi have the ability to change how they interact with various drugs,” she explained.
Professor O’s study focused on a fungus called D. elegans. “
These studies also show that the effect of the compound on the brain is not a direct effect on the cells in the brain, but it is a direct and important interaction between the cells and the fungus.”
Professor O’s study focused on a fungus called D. elegans.
It grows in the soil and produces spores that can be used for medicinal purposes.
It was previously shown to be effective in treating multiple sclerosis, Parkinson’s disease and Alzheimer’s.
Dr David Poulin from the National Drug and Alcohol Research Centre in Sydney said this research showed there was a lot of interest in the field of medicinal mushrooms, and it was exciting they could be harnessed for medicinal uses.
“The main idea behind medicinal mushrooms is they are very interesting for a variety of reasons,” he said.
“First and foremost, they are a great source of medicinal nutrients and they are also known for being very effective in the treatment of many diseases, including Alzheimer’s.”
He said the research was also an important step forward in understanding the mechanisms involved in the growth of fungus.
“For example, we know that fungus in the plant stage is an extremely diverse and diverse community of bacteria, fungi, archaea, protozoa, protoplasts, and viruses,” Dr Pouin said.
He said it had been difficult to identify the exact mechanisms by which these different fungi interact, because it had never been known how they functioned.
He and his colleagues are now looking to further explore the interactions of other fungi in the future.
“Our next step is to explore how other fungi might interact with the drug we are currently testing in mice,” Dr O’Connor said.